The state of cancer mortality, incidence: 9 new findings

The state of cancer mortality, incidence: 9 new findings
Becker's Hospital Review; bElizabeth Gregerson;4/21/25
Overall cancer mortality rates decreased for men, women and children in the U.S. between 2018 and 2022, according to the National Cancer Institute’s “Annual Report to the Nation on the Status of Cancer,” published April 21 in Cancer. The report presents cancer incidence and mortality data collected from NCI and CDC population-based cancer registries, as well as from the National Center for Health Statistics’ National Vital Statistics System, according to an April 21 news release from the NCI. Here are nine notes from the report:

• Between 2018 and 2022, cancer mortality decreased an average of 1.7% per year for men and 1.3% per year for women. Between 2001 and 2022, cancer mortality decreased 1.5% per year for children. For adolescents and young adults, cancer death rates decreased by 2.9% per year between 2001 and 2005, by 1% per year between 2005 and 2020, and remained stable from 2020 to 2022.
• For men, cancer mortality rates decreased for the following cancers between 2018 and 2022: prostate, liver and intrahepatic bile duct, esophagus, melanoma of the skin, kidney and renal pelvis, urinary bladder, colon and rectum, leukemia, myeloma, stomach, non-Hodgkin lymphoma, and lung and bronchus. Mortality rates increased for the following cancers: pancreas, bones and joints, oral cavity and pharynx, and non-melanoma skin cancer.
• For women, cancer mortality rates decreased for the following cancers between 2018 and 2022: brain and other nervous system, cervix, soft tissue including heart, urinary bladder, kidney and renal pelvis, breast, stomach, leukemia, colon and rectum, myeloma, gallbladder, non-Hodgkin lymphoma, ovary, and lung and bronchus. Mortality rates increased for the following cancers: oral cavity and pharynx, corpus and uterus, and liver and intrahepatic bile duct.
• [Click the link above to continue reading the rest of the list...]